Linical Co Ltd
TSE:2183

Watchlist Manager
Linical Co Ltd Logo
Linical Co Ltd
TSE:2183
Watchlist
Price: 311 JPY 0.32% Market Closed
Market Cap: ¥7.7B

Net Margin

-12%
Current
Declining
by 13%
vs 3-y average of 1%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-12%
=
Net Income
¥-1.2B
/
Revenue
¥9.9B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-12%
=
Net Income
¥-1.2B
/
Revenue
¥9.9B

Peer Comparison

Country Company Market Cap Net
Margin
JP
Linical Co Ltd
TSE:2183
7B JPY
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.2T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
218.1B USD
Loading...
US
Danaher Corp
NYSE:DHR
154.8B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
36B CHF
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.1B CNY
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
39.3B USD
Loading...
US
Agilent Technologies Inc
NYSE:A
37.8B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.2B USD
Loading...
US
Illumina Inc
NASDAQ:ILMN
22.2B USD
Loading...

Market Distribution

Lower than 95% of companies in Japan
Percentile
5th
Based on 6 917 companies
5th percentile
-12%
Low
-122 700% — 2.9%
Typical Range
2.9% — 8.5%
High
8.5% — 63 031.4%
Distribution Statistics
Japan
Min -122 700%
30th Percentile 2.9%
Median 5.4%
70th Percentile 8.5%
Max 63 031.4%

Linical Co Ltd
Glance View

Linical Co., Ltd. engages in pharmaceutical contract research projects providing consulting, monitoring, and quality control services to pharmaceutical companies. The company is headquartered in Osaka, Osaka-Fu and currently employs 845 full-time employees. The company went IPO on 2008-10-27. The firm operates in two businesses. The CRO segment is engaged in the provision of contract monitoring, quality management and consulting services for phase II and phase III in drug development processes. The Pharmaceutical Sales Support segment is engaged in provision of pharmaceutical sales support for medical institutions in the downstream market.

Intrinsic Value
618.59 JPY
Undervaluation 50%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-12%
=
Net Income
¥-1.2B
/
Revenue
¥9.9B
What is Linical Co Ltd's current Net Margin?

The current Net Margin for Linical Co Ltd is -12%, which is below its 3-year median of 1%.

How has Net Margin changed over time?

Over the last 3 years, Linical Co Ltd’s Net Margin has decreased from 8.4% to -12%. During this period, it reached a low of -12% on Oct 30, 2025 and a high of 8.4% on Aug 30, 2022.

Back to Top